- Home
- EDUC vs AEON Comparison
EDUC vs AEON Comparison
Compare EDUC & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EDUC | AEON |
|---|---|---|
| Founded | 1965 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8M | 10.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EDUC | AEON |
|---|---|---|
| Price | $1.31 | $1.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.20 |
| AVG Volume (30 Days) | 24.4K | ★ 163.3K |
| Earning Date | 01-12-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $29,415,900.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.92 | $0.38 |
| 52 Week High | $1.93 | $49.11 |
Technical Indicators
Market Signals| Indicator | EDUC | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 49.94 | 62.98 |
| Support Level | $1.23 | $0.72 |
| Resistance Level | $1.34 | $1.10 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 73.33 | 81.26 |
Price Performance
Historical ComparisonAbout EDUC Educational Development Corporation
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.